U.S. Food and Drug Administration
NPA Files Citizen’s Petition With FDA on Specific CBD Relief
On Feb. 22, in a Citizen’s Petition to the U.S. Food and Drug Administration (FDA), the Natural Products Association (NPA) requested the FDA either: Determine cannabidiol (CBD) is not excluded from the definition of a dietary supplement under 21 U.S.C. §321(ff)(3)(B) allowing the Commissioner the ability to exercise enforcement discretion in a specific and selective ...
Senate Confirms Robert Califf as FDA Commission, Associations Respond
On Feb.15, the U.S. Senate confirmed Dr. Robert Califf to lead the U.S. Food and Drug Administration (FDA) for a second time in a 50-46 vote. In response to the confirmation, the Natural Products Association (NPA), the Council for Responsible Nutrition (CRN), and the Consumer Healthcare Products Association (CHPA) released the following statements: “This agency ...
ICYMI: NPA’s Fabricant Appears on CBS “The Doctors”
Daniel Fabricant, PhD., president and CEO of the Natural Products Association (NPA) and the former chief regulator of the dietary supplement industry appeared on the CBS show “The Doctors” on February 7, 2022. Fabricant discussed the unintended consequences of legislation in California that would place age restrictions on nutritional supplements. The legislation recently passed by ...
California Assembly Votes to Restrict Access to Supplements, NPA Responds
On Jan. 27, the California Assembly passed legislation by a vote of 44-12 that would place age restrictions on nutritional supplements and impose costly burdens on small businesses. The bill will now go through the committee process in the California Senate. The Natural Products Association (NPA) warns that the bill will lead to unintended consequences that include ...
TopGum Triples Capacity With $30M Investment in New Plant
Gummy supplement manufacturer TopGum Industries, Ltd. has begun construction of a new, $30 million (U.S.), 11,000m2 plant 1.5 hours south of Tel Aviv, Israel. The facility, joining the company’s existing production plant, is expected to be fully operated in mid-2023 and triple the TopGum’s production capacity. Fully equipped with high-precision manufacturing technology adapted to TopGum’s ...
Lycored Opens New Facility in New Jersey
Lycored has launched a state-of-the-art processing facility in Branchburg, NJ for its carotenoids, vitamins, minerals, amino acids and real food ingredients. The new plant enables the company to maximize the purity, efficacy and shelf-stability of its ingredients while exponentially increasing output capacity. It provides advanced capabilities for milling, blending, drying and coating, with extensive opportunities ...
FDA Announces Qualified Health Claim for Magnesium and Reduced Risk of High Blood Pressure
In a letter of enforcement discretion released on Jan 10., the U.S. Food and Drug Administration (FDA) announced that it does not intend to object to the use of certain qualified health claims regarding the consumption of magnesium and a reduced risk of high blood pressure (hypertension), provided that the claims are appropriately worded to avoid misleading ...
NJ Labs to Release ‘Going Beyond Testing’ Podcast Series
New Jersey-based NJ Labs will release a new podcast series called, ‘Going Beyond Testing’ in 2022 to give companies and consumers an insider’s look at testing practices and what should be tested to keep products safe and effective. The series will cover the importance of analytical testing, emphasizing transparency and integrity in the testing practices and ...
NPA Sues FDA: Asks Courts to Block “Unlawful Action” in NAC Situation
The Natural Products Association (NPA) filed a lawsuit against the U.S. Food and Drug Administration (FDA) requesting that the agency cease its unlawful retroactive application of the Food, Drug and Cosmetic Act against N-acetyl-L-cysteine (NAC). “We are very concerned that a safe, legal natural product that has been sold for over 30 years is under ...
Associations Comment on the Nomination of Robert M. Califf for FDA Commissioner
On Nov. 12, President Biden announced that he will nominate Robert M. Califf, MD for commissioner of the U.S. Food and Drug Administration (FDA). Califf is an internationally recognized expert in clinical trial research, health disparities, health care quality and cardiovascular medicine. He has nearly four decades of experience as a doctor, researcher, leader and ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
